FGEN
FibroGen, Inc.
Set alert
- YTD
- +3.30%
- 1 year
- -41.90%
- Open
- 9.10
- Prev close
- 9.07
- Mkt cap
- 48.37M
- Vol
- 29.25K
- Avg vol
- 1.21M
- EPS
- -1.23
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 9.02
- High
- 9.21
- Forward P/E
- -0.70
- Beta
- 0.73
- Short ratio
- 3.27
- Inst. own
- 55.04%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.35386
- 200-d avg
- 0.852785
- 1y target
- 10.00
News
7 months ago globenewswire.com
Kyntra Bio to Report Fourth Quarter and Full Year 2025 Financial Results
SAN FRANCISCO, March 09, 2026 (GLOBE NEWSWIRE) -- Kyntra Bio (Nasdaq: KYNB), formerly FibroGen (Nasdaq: FGEN), will announce fourth quarter and full year 2025 financial results on Monday, March 16…
8 months ago globenewswire.com
Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026
SAN FRANCISCO, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Kyntra Bio (Nasdaq: KYNB), formerly FibroGen (Nasdaq: FGEN), today announced that the data on anti-tumor activity of FG-3246 in combination with…
9 months ago defenseworld.net
FibroGen (NASDAQ:FGEN) Stock Crosses Above Fifty Day Moving Average – Here’s Why
FibroGen, Inc (NASDAQ: FGEN - Get Free Report) shares crossed above its 50 day moving average during trading on Friday. The stock has a 50 day moving average of $8.96 and traded as high as $9.75.…
9 months ago globenewswire.com
FibroGen Rebrands as Kyntra Bio to Reflect a New Era of Focus and Momentum
SAN FRANCISCO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- FibroGen, Inc. (Nasdaq: FGEN), today announced it is rebranding the company to Kyntra Bio, representing the next step of the transformation of the…
10 months ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
11 months ago seekingalpha.com
FibroGen, Inc. (FGEN) Q3 2025 Earnings Call Transcript
FibroGen, Inc. ( FGEN ) Q3 2025 Earnings Call November 10, 2025 5:00 PM EST Company Participants Thane Wettig - CEO & Director David DeLucia - Senior VP & CFO Conference Call Participants Gaia…
11 months ago zacks.com
FibroGen (FGEN) Reports Q3 Loss, Lags Revenue Estimates
FibroGen (FGEN) came out with a quarterly loss of $1.61 per share versus the Zacks Consensus Estimate of a loss of $4.01. This compares to a loss of $4.25 per share a year ago.
12 months ago globenewswire.com
FibroGen to Report Third Quarter 2025 Financial Results
SAN FRANCISCO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce third quarter 2025 financial results on Monday, November 10 after market close. FibroGen will also conduct…
1 year ago globenewswire.com
FibroGen Initiates Phase 2 Monotherapy Trial of FG-3246, a First-in-Class CD46 Targeting ADC, in Metastatic Castration-Resistant Prostate Cancer
SAN FRANCISCO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the initiation of the Phase 2 monotherapy, dose-optimization trial of FG-3246, a potential…
1 year ago globenewswire.com
FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference
SAN FRANCISCO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending and presenting at the H.C. Wainwright 27th Annual Global Investment…
1 year ago globenewswire.com
FibroGen Announces Approval of Sale of FibroGen China to AstraZeneca by the China State Administration for Market Regulation
SAN FRANCISCO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the China State Administration for Market Regulation approved the sale of FibroGen International…
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
1 year ago seekingalpha.com
FibroGen, Inc. (FGEN) Q2 2025 Earnings Call Transcript
FibroGen, Inc. (NASDAQ:FGEN ) Q2 2025 Earnings Conference Call August 11, 2025 5:00 PM ET Company Participants Carol Gaddum - Corporate Participant Product Team Lead - Corporate Participant David…
1 year ago zacks.com
FibroGen (FGEN) Reports Q2 Loss, Lags Revenue Estimates
FibroGen (FGEN) came out with a quarterly loss of $3.38 per share versus the Zacks Consensus Estimate of a loss of $2.25. This compares to a loss of $4 per share a year ago.
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
1 year ago globenewswire.com
FibroGen Reports Second Quarter 2025 Financial Results and Provides Business Update
SAN FRANCISCO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today reported financial results for the second quarter 2025 and provided an update on the company's recent developments.
-
1 year ago benzinga.com
Earnings Scheduled For August 11, 2025
Earnings Scheduled For August 11, 2025
1 year ago globenewswire.com
FibroGen to Report Second Quarter 2025 Financial Results
SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce second quarter 2025 financial results on Monday, August 11 after the markets close. FibroGen will also…
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
1 year ago benzinga.com
Adobe, FibroGen And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling more than 500 points on Friday.
1 year ago benzinga.com
Why RH Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Why RH Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
1 year ago globenewswire.com
FibroGen Announces 1-for-25 Reverse Stock Split
SAN FRANCISCO, June 12, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that it will implement a 1-for-25 reverse stock split of its issued and outstanding common stock…
1 year ago globenewswire.com
FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors
SAN FRANCISCO, June 09, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the appointment of Dr. Michael Kauffman to its Board of Directors effective June 4, 2025.
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
1 year ago seekingalpha.com
FibroGen, Inc. (FGEN) Q1 2025 Earnings Call Transcript
FibroGen, Inc. (NASDAQ:FGEN ) Q1 2025 Earnings Conference Call May 12, 2025 5:00 PM ET Company Participants Joanne Greller - LifeSci Advisors Thane Wettig - Chief Executive Officer David DeLucia -…
1 year ago zacks.com
FibroGen (FGEN) Reports Q1 Loss, Tops Revenue Estimates
FibroGen (FGEN) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of $0.03. This compares to loss of $0.33 per share a year ago.
1 year ago globenewswire.com
FibroGen Reports First Quarter 2025 Financial Results and Provides Business Update
SAN FRANCISCO, May 12, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today reported financial results for the first quarter 2025 and provided an update on the company's recent developments.
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
-
1 year ago benzinga.com
Earnings Scheduled For November 12, 2024
Earnings Scheduled For November 12, 2024
-
2 years ago benzinga.com
Nasdaq Surges Over 3%; Powell Industries Shares Spike Higher
Nasdaq Surges Over 3%; Powell Industries Shares Spike Higher
-
2 years ago benzinga.com
Dow Jumps Over 200 Points; Kraft Heinz Shares Gain After Q2 Earnings
Dow Jumps Over 200 Points; Kraft Heinz Shares Gain After Q2 Earnings
-
2 years ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
-
2 years ago benzinga.com
Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
-
2 years ago benzinga.com
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
-
2 years ago benzinga.com
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
-
2 years ago benzinga.com
Why Zeta Global Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Why Zeta Global Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
-
2 years ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
-
2 years ago benzinga.com
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly…
-
2 years ago benzinga.com
Earnings Scheduled For February 26, 2024
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on revenue of $477.73 million.
-
2 years ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
-
2 years ago benzinga.com
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.
-
2 years ago benzinga.com
Earnings Scheduled For November 6, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 311 stocks hit new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 275 companies made new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
Friday's session saw 169 companies set new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 283 companies set new 52-week lows.
-
3 years ago benzinga.com
Why REX American Resources Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 89.5% to $2.7852 after the company reported outcomes from a UroShield study conducted at the University of Southampton in the U.K.
-
3 years ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session